I think you're right about the adoption rates and maintenance of the clients once adopted.
MedAdvisor, in conjunction with the pharmacies, need to be promoting/teaching the usefulness of the app in-store. Not enough is being done inside the pharmacy to adopt and keep new clients IMO.
I base this on my wife's experience as a current Intern Pharmacist at a reputable and well-known pharmacy brand. The employees and management are doing DIDDLY SQUAT to encourage use of the app. They are doing nothing to mine the client data for potential revenue streams.
In short, there is a disconnection between the customer, the app, and the business.
We are living in a time of peak app and technological distraction. How is the MedApp going to cut through the noise to be a useful sales tool for both client and pharmacy business alike when the employees are doing very little to promote and maintain its functions?
I am worried about the MedApp uptake and continued usage based on my limited and anecdotal observations...
- Forums
- ASX - By Stock
- MDR
- Medadvisor stearing patients away from smaller pharmacies?
Medadvisor stearing patients away from smaller pharmacies?, page-11
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MDR (ASX) to my watchlist
(20min delay)
|
|||||
Last
29.5¢ |
Change
0.005(1.72%) |
Mkt cap ! $215.0M |
Open | High | Low | Value | Volume |
29.0¢ | 29.5¢ | 27.5¢ | $248.7K | 869.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 24636 | 27.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
29.5¢ | 13888 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 15939 | 0.335 |
3 | 26030 | 0.330 |
1 | 100000 | 0.325 |
4 | 89161 | 0.320 |
2 | 29526 | 0.315 |
Price($) | Vol. | No. |
---|---|---|
0.360 | 24455 | 1 |
0.380 | 50000 | 1 |
0.385 | 100000 | 1 |
0.390 | 54500 | 1 |
0.395 | 10000 | 1 |
Last trade - 15.28pm 15/11/2024 (20 minute delay) ? |
MDR (ASX) Chart |